Dapagliflozin/Metformin Combo Nears EU Approval for DiabetesDapagliflozin/Metformin Combo Nears EU Approval for Diabetes

The first product combining metformin with an SGLT2 inhibitor, dapagliflozin, has been granted a positive opinion by the European Medicines Agency for use in type 2 diabetes. Medscape Medical News
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news